• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Xenon Pharmaceuticals Inc. - Common Shares (NQ:XENE)

56.40 -0.69 (-1.21%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Xenon Pharmaceuticals Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
A Look Ahead: Xenon Pharmaceuticals's Earnings Forecast ↗
August 08, 2025
 
Via Benzinga
News headline image
Xenon to Report Q2 2025 Financial Results on August 11, 2025
August 04, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Biogen Shares Slip After $46M Research Charge Hits Quarterly Profit ↗
July 07, 2025
The company anticipates a research expense in Q2 associated with milestone and licensing payments, which will impact both GAAP and non-GAAP earnings per share. 
Via Stocktwits
News headline image
Earnings Scheduled For May 12, 2025 ↗
May 12, 2025
 
Via Benzinga
News headline image
What to Expect from Xenon Pharmaceuticals's Earnings ↗
May 09, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For February 27, 2025 ↗
February 27, 2025
 
Via Benzinga
News headline image
Xenon Joins the Russell 3000® and Russell 2000® Indexes
June 27, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 26, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon Announces Appointment of Darren Cline as Chief Commercial Officer
June 24, 2025
Mr. Cline brings extensive commercial expertise to lead the transition of Xenon to a commercial-stage company with the anticipated launch of azetukalner across three potential indications 
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
June 03, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 30, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference
May 14, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Crude Oil Gains 3%; US Inflation Eases In April ↗
May 13, 2025
 
Via Benzinga
Topics Economy
News headline image
Xenon Reports First Quarter 2025 Financial Results and Provides Business Update
May 12, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
This Discover Financial Services Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗
May 07, 2025
 
Via Benzinga
News headline image
This Waste Connections Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗
May 07, 2025
 
Via Benzinga
News headline image
Xenon to Report Q1 2025 Financial Results on May 12, 2025
May 05, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 02, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025
April 04, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon to Present at Stifel 2025 Virtual CNS Forum
March 12, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update
February 27, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon to Present at the 45th Annual TD Cowen Healthcare Conference
February 25, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon to Report Q4 and Full Year 2024 Financial Results on February 27, 2025
February 20, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon Outlines Key Corporate Milestone Opportunities for 2025
January 13, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 07, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024
December 06, 2024
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon to Showcase New Long-Term Azetukalner Data at AES 2024
November 25, 2024
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon to Present at Upcoming Investor Conferences
November 13, 2024
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Xenon Reports Q3 2024 Financial Results and Business Update
November 12, 2024
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap